Report

src

Biologics CDMO Market, By Type: (Plant-based and Microbial & Mammalian based), By Type of Service (Development Services and Manufacturing Services), By End-use Industry (Big Pharma, Small Pharma, Generic Pharma, and Others) Market - Growth, Future Prospects, Post COVID-19 Scenario 2021 - 2028

 Report Code
 Category
 Published Date
 Pages
 Format
MNR-1511
Agriculture
28 July 2021
247
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

The contract development and manufacturing organizations  primarily serves other biopharmaceutical companies by addressing major challenges and help to fasten the drug development and manufacturing process. With the growing pharmaceutical industry, need for CDMO has increased at significant rate. The immense growth of the biologics CDMO is mainly due to technological advances in drug development and manufacturing process. In addition, companies are collaborating to offer wide scale operations to small- and large-scale pharmaceutical companies to increase the speed of research and manufacturing process. This will further boost the biologics CDMO market over the forecast period.

Current COVID-19 pandemic conditions positively affected the growth of the market. With the increasing need of vaccine development many bio pharmaceutical companies  approached CDMO to fasten the process of vaccine development and its cost effective production. Besides, the demand for CDMO is expected to remain high over the forecast period owing to occurrence of newer viral and bacterial diseases.

The global biologics CDMO market is classified based on type, type of service, and end use industry. Based on the type, the global biologics CDMO market is categorized into plant-based and microbial & mammalian based. The type of service offered by biologics CDMO is divided into development services and manufacturing services. The end-use industry segment is segmented as big pharma, small pharma, generic pharma, and others.

Some of the major players operating in the market include Lonza Group AG, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, Samsung BioLogics, AGC Biologics, Inc., Catalent, Inc., Wuxi Biologics, Medicago Inc., iBio Inc., Protalix-Pfizer, Mapp Biopharmaceautical - Leaf Bio, Ventria Bioscience, Kentucky BioProcessing, Inc., PhycoBiologics, INC., Synthon International Holding B.V., Fraunhofer, and Icon Genetics GmbH.

Global Biologics CDMO Market, By Type
Based on the type the global biologics CDMO market is bifurcated into the following
  • Plant-based
  • Microbial & Mammalian based
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Biologics CDMO Value Share, By Type, 2019 & 2028(% Value)


In 2020, microbial & mammalian based segment held the largest share of the market. Microbial and mammalian are the most common systems used to derive vaccine and other biological drugs. Availability of large number of vector systems and compatibility with human body are some of the key factors contributing for the large share of the segment.

Global Biologics CDMO Market, By Type of Service
Based on the type of service the global biologics CDMO market is bifurcated into the following
  • Development Services
  • Manufacturing Services
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Biologics CDMO Value Share, By Type of Service, 2019 & 2028(% Value)


In 2020, manufacturing services held the largest share of the market. Increasing demand from small scale pharmaceutical companies for optimized manufacturing process is primarily contributing for the large share of the segment in the overall market.

Global Biologics CDMO Market, By End Use Industry
Based on the end use industry the global biologics CDMO market is bifurcated into the following
  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • Others
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Biologics CDMO Value Share, By End Use Industry, 2019 & 2028(% Value)


In 2020, small pharma segment held the largest share of the market. Increasing demand for drug discovery and optimized manufacturing process owing to unavailability of well-established research facilities and manufacturing units in small scale pharmaceuticals is primarily driving the growth of the segment.

Global Biologics CDMO Market, By Geography
Based on geography, the biologics CDMO market is segmented into following:
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Biologics CDMO Value Share, By Geography, 2019 & 2028(% Value)


In 2020, North America held the largest share of the market. High spending on drug research, presence of key contract development and manufacturing organizations, and large pharmaceutical industry is primarily supporting the growth of the market in North America. On the other hand, increasing number of CDMO in India and China is expected to spur the market growth in Asia Pacific over the forecast period.

Chapter 1    Preface
        1.1    Report Description
                1.1.1    Aim of the Report
                1.1.2    Report Target Audience
                1.1.3    Report Offering
        1.2    Research Scope
        1.3    Research Methodology
                1.3.1    Phase I – Secondary Research
                1.3.2    Phase II – Primary Research
                1.3.3    Phase III – Expert Panel Review
                1.3.4    Assumptions
                1.3.5    Top-Down and Bottom-Up Approach

Chapter 2    Executive Summary
        2.1    Market Snapshot: Global Biologics CDMO Market
        2.2    Global Biologics CDMO Market, By Type
        2.3    Global Biologics CDMO Market, By Type of Service
        2.4    Global Biologics CDMO Market, By End User
        2.5    Global Biologics CDMO Market, By Geography

Chapter 3    Market Dynamics
        3.1    Product and Market Insights
                3.1.1    Global Biologics CDMO Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
        3.2    Market Dynamics
                3.2.1    Growth Drivers
                3.2.2    Market Restraints
                3.2.3    Impact Analysis of Drivers and Restraints
                3.2.4    COVID-19 Impact
        3.3    Attractive Investment Proposition
        3.4    Competitive Analysis
                3.4.1    Competitive Landscape in the Biologics CDMO Market

Chapter 4    Global Biologics CDMO Market Analysis, By Type
        4.1    Overview
        4.2    Plant-based
                4.2.1    Global Plant-based Market Value, 2018 – 2028, (US$ Mn)
        4.3    Microbial-based
                4.3.1    Global Microbial-based Market Value, 2018 – 2028, (US$ Mn)

Chapter 5    Global Biologics CDMO Market Analysis, By Type of Service
        5.1    Overview
        5.2    Development Services
                5.2.1    Global Development Services Market Value, 2018 – 2028, (US$ Mn)
        5.3    Manufacturing Services
                5.3.1    Global Manufacturing Services Market Value, 2018 – 2028, (US$ Mn)

Chapter 6    Global Biologics CDMO Market Analysis, By End User
        6.1    Overview
        6.2    Big Pharma
                6.2.1    Global Big Pharma Market Value, 2018 – 2028, (US$ Mn)
        6.3    Small Pharma
                6.3.1    Global Small Pharma Market Value, 2018 – 2028, (US$ Mn)
        6.4    Generic Pharma
                6.4.1    Global Generic Pharma Market Value, 2018 – 2028, (US$ Mn)
        6.5    Others
                6.5.1    Global Others Market Value, 2018 – 2028, (US$ Mn)

Chapter 7    North America Biologics CDMO Market Analysis
        7.1    Overview
        7.2    North America Biologics CDMO Market Analysis, By Type, 2018 – 2028
                7.2.1    Market Analysis
        7.3    North America Biologics CDMO Market Analysis, By Type of Service, 2018 – 2028
                7.3.1    Market Analysis
        7.4    North America Biologics CDMO Market Analysis, By End User, 2018 – 2028
                7.4.1    Market Analysis
        7.5    North America Biologics CDMO Market Analysis, By Country, 2018 – 2028
                7.5.1    Market Analysis
                7.5.2    U.S.
                7.5.3    Canada

Chapter 8    Europe Biologics CDMO Market Analysis
        8.1    Overview
        8.2    Europe Biologics CDMO Market Analysis, By Type, 2018 – 2028
                8.2.1    Market Analysis
        8.3    Europe Biologics CDMO Market Analysis, By Type of Service, 2018 – 2028
                8.3.1    Market Analysis
        8.4    Europe Biologics CDMO Market Analysis, By End User, 2018 – 2028
                8.4.1    Market Analysis
        8.5    Europe Biologics CDMO Market Analysis, By Country, 2018 – 2028
                8.5.1    Market Analysis
                8.5.2    UK
                8.5.3    Germany
                8.5.4    France
                8.5.5    Rest of Europe

Chapter 9    Asia Pacific Biologics CDMO Market Analysis
        9.1    Overview
        9.2    Asia Pacific Biologics CDMO Market Analysis, By Type, 2018 – 2028
                9.2.1    Market Analysis
        9.3    Asia Pacific Biologics CDMO Market Analysis, By Type of Service, 2018 – 2028
                9.3.1    Market Analysis
        9.4    Asia Pacific Biologics CDMO Market Analysis, By End User, 2018 – 2028
                9.4.1    Market Analysis
        9.5    Asia Pacific Biologics CDMO Market Analysis, By Country, 2018 – 2028
                9.5.1    Market Analysis
                9.5.2    China
                9.5.3    Japan
                9.5.4    India
                9.5.5    Rest of Asia Pacific

Chapter 10    Latin America Biologics CDMO Market Analysis
        10.1    Overview
        10.2    Latin America Biologics CDMO Market Analysis, By Type, 2018 – 2028
                10.2.1    Market Analysis
        10.3    Latin America Biologics CDMO Market Analysis, By Type of Service, 2018 – 2028
                10.3.1    Market Analysis
        10.4    Latin America Biologics CDMO Market Analysis, By End User, 2018 – 2028
                10.4.1    Market Analysis
        10.5    Latin America Biologics CDMO Market Analysis, By Country, 2018 – 2028
                10.5.1    Market Analysis
                10.5.2    Mexico
                10.5.3    Brazil
                10.5.4    Rest of Latin America

Chapter 11    Middle East and Africa (MEA) Biologics CDMO Market Analysis
        11.1    Overview
        11.2    MEA Biologics CDMO Market Analysis, By Type, 2018 – 2028
                11.2.1    Market Analysis
        11.3    MEA Biologics CDMO Market Analysis, By Type of Service, 2018 – 2028
                11.3.1    Market Analysis
        11.4    MEA Biologics CDMO Market Analysis, By End User, 2018 – 2028
                11.4.1    Market Analysis
        11.5    MEA Biologics CDMO Market Analysis, By Country, 2018 – 2028
                11.5.1    Market Analysis
                11.5.2    GCC Countries
                11.5.3    South Africa
                11.5.4    Rest of MEA

Chapter 12    Company Profiles
        12.1    Lonza Group AG
                12.1.1    Lonza Group AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.2    Boehringer Ingelheim BioXcellence
                12.2.1    Boehringer Ingelheim BioXcellence: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.3    Thermo Fisher Scientific
                12.3.1    Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.4    Samsung BioLogics
                12.4.1    Samsung BioLogics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.5    AGC Biologics, Inc.
                12.5.1    AGC Biologics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.6    Catalent, Inc.
                12.6.1    Catalent, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.7    Wuxi Biologics
                12.7.1    Wuxi Biologics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.8    Medicago Inc.
                12.8.1    Medicago Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.9    iBio Inc.
                12.9.1    iBio Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        12.10    Protalix-Pfizer
                12.10.1    Protalix-Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.11    Mapp Biopharmaceautical - Leaf Bio
                        12.11.1    Mapp Biopharmaceautical - Leaf Bio: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.12    Ventria Bioscience
                        12.12.1    Ventria Bioscience: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.13    Kentucky BioProcessing, Inc.
                        12.13.1    Kentucky BioProcessing, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.14    PhycoBiologics, INC.
                        12.14.1    PhycoBiologics, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.15    Synthon International Holding B.V.
                        12.15.1    Synthon International Holding B.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.16    Fraunhofer
                        12.16.1    Fraunhofer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
                12.17    Icon Genetics GmbH
                        12.17.1    Icon Genetics GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        
        

List of Figures



        
        FIG. 1    Global Biologics CDMO Market: Research Methodology
        FIG. 2    Top-Down and Bottom Up Approach
        FIG. 3    Global Biologics CDMO Market, By Type, 2020 (US$ Mn)
        FIG. 4    Global Biologics CDMO Market, By Type of Service, 2020 (US$ Mn)
        FIG. 5    Global Biologics CDMO Market, By End User, 2020 (US$ Mn)
        FIG. 6    Global Biologics CDMO Market, By Geography, 2020 (US$ Mn)
        FIG. 7    Global Biologics CDMO Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
        FIG. 8    Attractive Investment Proposition
        FIG. 9    Market Positioning of Key Biologics CDMO Providers, 2020
        FIG. 10    Global Biologics CDMO Market Value Share, By Type, 2020 & 2028 (% Value)
        FIG. 11    Global Plant-based Market Value, 2018 – 2028, (US$ Mn)
        FIG. 12    Global Microbial-based Market Value, 2018 – 2028, (US$ Mn)
        FIG. 13    Global Biologics CDMO Market Value Share, By Type of Service, 2020 & 2028 (% Value)
        FIG. 14    Global Development Services Market Value, 2018 – 2028, (US$ Mn)
        FIG. 15    Global Manufacturing Services Market Value, 2018 – 2028, (US$ Mn)
        FIG. 16    Global Biologics CDMO Market Value Share, By End User, 2020 & 2028 (% Value)
        FIG. 17    Global Big Pharma Market Value, 2018 – 2028, (US$ Mn)
        FIG. 18    Global Small Pharma Market Value, 2018 – 2028, (US$ Mn)
        FIG. 19    Global Generic Pharma Market Value, 2018 – 2028, (US$ Mn)
        FIG. 20    Global Others Market Value, 2018 – 2028, (US$ Mn)
        FIG. 21    U.S. Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 22    Canada Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 23    UK Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 24    Germany Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 25    France Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 26    Rest of Europe Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 27    China Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 28    Japan Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 29    India Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 30    Rest of Asia Pacific Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 31    Mexico Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 32    Brazil Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 33    Rest of Latin America Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 34    GCC Countries Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 35    South Africa Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)
        FIG. 36    Rest of MEA Biologics CDMO Market Value, 2018 – 2028, (US$ Mn)

List of Tables



TABLE 1    Market Snapshot: Global Biologics CDMO Market
TABLE 2    Impact Pointers
TABLE 3    Impact Analysis of Drivers and Restraints
TABLE 4    North America Biologics CDMO Market Value, By Type, 2018 – 2028
TABLE 5    North America Biologics CDMO Market Value, By Type of Service, 2018 – 2028
TABLE 6    North America Biologics CDMO Market Value, By End User, 2018 – 2028
TABLE 7    North America Biologics CDMO Market Value, By Country, 2018 – 2028
TABLE 8    Europe Biologics CDMO Market Value, By Type, 2018 – 2028
TABLE 9    Europe Biologics CDMO Market Value, By Type of Service, 2018 – 2028
TABLE 10    Europe Biologics CDMO Market Value, By End User, 2018 – 2028
TABLE 11    Europe Biologics CDMO Market Value, By Country, 2018 – 2028
TABLE 12    Asia Pacific Biologics CDMO Market Value, By Type, 2018 – 2028
TABLE 13    Asia Pacific Biologics CDMO Market Value, By Type of Service, 2018 – 2028
TABLE 14    Asia Pacific Biologics CDMO Market Value, By End User, 2018 – 2028
TABLE 15    Asia Pacific Biologics CDMO Market Value, By Country, 2018 – 2028
TABLE 16    Latin America Biologics CDMO Market Value, By Type, 2018 – 2028
TABLE 17    Latin America Biologics CDMO Market Value, By Type of Service, 2018 – 2028
TABLE 18    Latin America Biologics CDMO Market Value, By End User, 2018 – 2028
TABLE 19    Latin America Biologics CDMO Market Value, By Country, 2018 – 2028
TABLE 20    MEA Biologics CDMO Market Value, By Type, 2018 – 2028
TABLE 21    MEA Biologics CDMO Market Value, By Type of Service, 2018 – 2028
TABLE 22    MEA Biologics CDMO Market Value, By End User, 2018 – 2028
TABLE 23    MEA Biologics CDMO Market Value, By Country, 2018 – 2028
TABLE 24    Lonza Group AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 25    Boehringer Ingelheim BioXcellence: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 26    Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 27    Samsung BioLogics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 28    AGC Biologics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 29    Catalent, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 30    Wuxi Biologics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 31    Medicago Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 32    iBio Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 33    Protalix-Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 34    Mapp Biopharmaceautical - Leaf Bio: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 35    Ventria Bioscience: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 36    Kentucky BioProcessing, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 37    PhycoBiologics, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 38    Synthon International Holding B.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 39    Fraunhofer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 40    Icon Genetics GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)



 

No Methodology

No Available

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase